Imagine waking up every morning with a mind already racing—dozens of thoughts competing for attention, from what’s due at work to what was left unfinished yesterday. For the 6.1 million children and over 10 million adults in the U.S. living with ADHD, this isn’t just a busy day—it’s every day. Now imagine that even the simple act of picking out clothes feels overwhelming. The cluttered closet becomes a barrier. Getting dressed becomes another stressor.
This is where The Bright Hanger comes in.
Born from the intersection of empathy, neuroscience, and innovation, The Bright Hanger is not just a device—it’s a daily companion designed to empower those who process the world differently. Developed with guidance from cognitive behavioral therapy (CBT), it uses auditory and visual cues to guide users toward consistent clothing organization habits. Each time an item is placed or removed, the hanger responds—affirming structure, offering positive reinforcement, and reducing mental load.
The market's rapid growth presents a compelling opportunity for innovative solutions like The Bright Hanger, which directly addresses the rising demand for tools that support individuals with ADHD in managing daily routines. This creates a timely and strategic entry point for investors to participate in a high-impact, high-potential segment of the ADHD support market.
ADHD isn’t just about focus—it’s about executive function: planning, organizing, and remembering. A disorganized closet is more than a mess—it’s a trigger for anxiety, shame, and inefficiency. The Bright Hanger is a small, affordable intervention with transformative potential, making independence and confidence more accessible—starting in the closet.
We’re not just creating a hanger. We’re creating a movement—where organization is accessible, structure is supportive, and neurodiversity is celebrated through smart, human-first design.
Invest in The Bright Hanger—and help millions start their day with clarity, confidence, and control.
We are seeking seed funding to finalize manufacturing, expand clinical validation studies, and launch a direct-to-consumer and B2B education-based rollout. Your investment will:
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.